BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36502584)

  • 1. Central nervous system metastasis from epithelial ovarian cancer- predictors of outcome.
    Jayraj AS; Kumar S; Bhatla N; Malik PS; Mathur S; Rangarajan K; Vanamail P; Thulkar S; Kumar L
    Curr Probl Cancer; 2023 Feb; 47(1):100918. PubMed ID: 36502584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platinum sensitivity and CD133 expression as risk and prognostic predictors of central nervous system metastases in patients with epithelial ovarian cancer.
    Liu BL; Liu SJ; Baskys A; Cheng H; Han Y; Xie C; Song H; Li J; Xin XY
    BMC Cancer; 2014 Nov; 14():829. PubMed ID: 25399490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain metastasis from ovarian carcinoma: Analysis of eight cases from a single radiotherapy center.
    Bahat Z; Cakmak VA; Cakir E
    Taiwan J Obstet Gynecol; 2020 Sep; 59(5):711-717. PubMed ID: 32917323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literature.
    Pectasides D; Aravantinos G; Fountzilas G; Kalofonos C; Efstathiou E; Karina M; Pavlidis N; Farmakis D; Economopoulos T; Dimopoulos MA
    Anticancer Res; 2005; 25(5):3553-8. PubMed ID: 16101179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival Impact of Optimal Surgical Cytoreduction in Recurrent Epithelial Ovarian Cancer with Brain Metastasis.
    Keskin S; Küçücük S; Ak N; Atalar B; Sarı M; Sozen H; Ibis K; Topuz S; Saip P
    Oncol Res Treat; 2019; 42(3):101-106. PubMed ID: 30661076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The relationship of preoperativelymphocyte-monocyte ratio and the clinicopathological characteristics and prognosis of patients with epithelial ovarian cancer].
    Yang HM; Lou G
    Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):676-680. PubMed ID: 28926896
    [No Abstract]   [Full Text] [Related]  

  • 7. Central nervous system metastatic epithelial ovarian cancer. Clinical parameters and prognostic factors: a multicenter study of Anatolian Society of Medical Oncology.
    Seber S; Turkmen E; Harputoğlu H; Yeşil H; Arpacι E; Menekşe S; Pilancι K; Oruç Z; Taskoylu BY; Gumusay O; Aksoy A; Karaagac M; Ozarslan E; Yetisyigit T
    Eur J Gynaecol Oncol; 2017; 38(2):227-231. PubMed ID: 29953785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation therapy for epithelial ovarian cancer brain metastases: clinical outcomes and predictors of survival.
    Teckie S; Makker V; Tabar V; Alektiar K; Aghajanian C; Hensley M; Beal K
    Radiat Oncol; 2013 Feb; 8():36. PubMed ID: 23414446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
    Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer.
    Chen JP; Huang QD; Wan T; Tu H; Gu HF; Cao JY; Liu JH
    J Ovarian Res; 2019 Jul; 12(1):72. PubMed ID: 31362750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes and prognostic factors of patients with epithelial ovarian cancer subjected to first-line treatment: a retrospective study of 251 cases.
    Fu Y; Wang X; Pan Z; Xie X
    Front Med; 2014 Mar; 8(1):91-5. PubMed ID: 24370920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central nervous system metastasis in gynecologic cancers: Seeking the prognostic factors.
    Minareci Y; Ak N; Tosun OA; Sozen H; Saip PM; Topuz S; Salihoglu MY
    J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S523-S529. PubMed ID: 38384014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of factors related to the prognostic benefit of neoadjuvant chemotherapy followed by interval debulking surgery in patients with advanced ovarian cancer].
    Wang DF; Zhang GN; Peng CR; Shi Y; Shi XW
    Zhonghua Fu Chan Ke Za Zhi; 2021 Jun; 56(6):385-392. PubMed ID: 34154313
    [No Abstract]   [Full Text] [Related]  

  • 14. Epithelial Ovarian Cancer Metastatic to the Central Nervous System and a Family History Concerning for Hereditary Breast and Ovarian Cancer--A Potential Relationship.
    Jernigan AM; Mahdi H; Rose PG
    Int J Gynecol Cancer; 2015 Sep; 25(7):1232-8. PubMed ID: 26067864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and prognostic significance of inguinal lymph node metastasis in women with newly diagnosed epithelial ovarian cancer.
    Chalif J; Yao M; Gruner M; Kuznicki M; Vargas R; Rose PG; Michener C; DeBernardo R; Chambers L
    Gynecol Oncol; 2022 Apr; 165(1):90-96. PubMed ID: 35272875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A late, solitary brain metastasis of epithelial ovarian carcinoma.
    Longo R; Platini C; Eid N; Elias-Matta C; Buda T; 'Nguyen D; Quétin P
    BMC Cancer; 2014 Jul; 14():543. PubMed ID: 25069863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary debulking surgery versus primary neoadjuvant chemotherapy for high grade advanced stage ovarian cancer: comparison of survivals.
    Kobal B; Noventa M; Cvjeticanin B; Barbic M; Meglic L; Herzog M; Bordi G; Vitagliano A; Saccardi C; Skof E
    Radiol Oncol; 2018 Sep; 52(3):307-319. PubMed ID: 30210049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a nomogram to predict survival outcome among epithelial ovarian cancer patients with site-distant metastases: a population-based study.
    Wang B; Wang S; Ren W
    BMC Cancer; 2021 May; 21(1):609. PubMed ID: 34034697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical Analysis of Stage IV Epithelial Ovarian Cancer Patients after Treatment with Neoadjuvant Chemotherapy followed by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).
    Munoz-Zuluaga CA; Sardi A; Sittig M; Gushchin V; King MC; Nieroda C; Lopez-Ramirez F; Diaz-Montes TP
    Int J Surg Oncol; 2020; 2020():1467403. PubMed ID: 33381312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the primary route of spread have a prognostic significance in stage III non-serous epithelial ovarian cancer?
    Sahin H; Meydanli MM; Sari ME; Yalcin I; Çoban G; Ozkan NT; Cuylan ZF; Erdem B; Gungorduk K; Akbayir Ö; Dede M; Salman MC; Güngör T; Ayhan A
    J Ovarian Res; 2018 Mar; 11(1):21. PubMed ID: 29506569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.